1 |
Cariello M, Zerlotin R, Pasculli E, Piccinin E, Peres C, Porru E, Roda A, Gadaleta RM, Moschetta A. Intestinal FXR Activation via Transgenic Chimera or Chemical Agonism Prevents Colitis-Associated and Genetically-Induced Colon Cancer. Cancers 2022;14:3081. [DOI: 10.3390/cancers14133081] [Reference Citation Analysis]
|
2 |
Huang X, Fan M, Huang W. Pleiotropic roles of FXR in liver and colorectal cancers. Mol Cell Endocrinol 2022;543:111543. [PMID: 34995680 DOI: 10.1016/j.mce.2021.111543] [Reference Citation Analysis]
|
3 |
Liu D, Zhao R, Wu Y, Wang Y, Yang R, Ke X. Variation in the Efficacy of Anti-Ulcerative Colitis Treatments Reveals the Conflict Between Precipitating Compatibility of Traditional Chinese Medicine and Modern Technology: A Case of Scutellaria-Coptis. Front Pharmacol 2022;13:819851. [PMID: 35517805 DOI: 10.3389/fphar.2022.819851] [Reference Citation Analysis]
|
4 |
Biagioli M, Marchianò S, Carino A, Di Giorgio C, Santucci L, Distrutti E, Fiorucci S. Bile Acids Activated Receptors in Inflammatory Bowel Disease. Cells 2021;10:1281. [PMID: 34064187 DOI: 10.3390/cells10061281] [Reference Citation Analysis]
|
5 |
Fiorito S, Epifano F, Marchetti L, Genovese S. Semisynthesis of Selenoauraptene. Molecules 2021;26:2798. [PMID: 34068532 DOI: 10.3390/molecules26092798] [Reference Citation Analysis]
|